|
41
|
Product specific BE guideline |
Lurasidone hydrochloride tablet_生體相等性試驗指導原則_V2(新增QA)
|
2025-09-24 |
|
42
|
Product specific BE guideline |
Metformin+Glimepiride tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
43
|
Product specific BE guideline |
Montelukast sodium Chewable Tablet, 5 mg, 4 mg_生體相等性試驗指導原則
|
2025-09-24 |
|
44
|
Product specific BE guideline |
Montelukast sodium Oral Granules 4 mg_生體相等性試驗指導原則
|
2025-09-24 |
|
45
|
Product specific BE guideline |
Montelukast sodium Tablets_生體相等性試驗指導原則
|
2025-09-24 |
|
46
|
Product specific BE guideline |
Nebivolol hydrochloride tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
47
|
Product specific BE guideline |
Silodosin Capsule_生體相等性試驗指導原則
|
2025-09-24 |
|
48
|
Product specific BE guideline |
Sitagliptin phosphate_Metformin HCl Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
49
|
Product specific BE guideline |
Sultamicillin tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
50
|
Product specific BE guideline |
Tamsulosin PR Tablet_生體相等性試驗指導原則
|
2025-09-24 |
